TASMAN PHARMA Trademark

Trademark Overview

On Tuesday, August 15, 2017, a trademark application was filed for TASMAN PHARMA with the United States Patent and Trademark Office. The USPTO has given the TASMAN PHARMA trademark a serial number of 87569014. The federal status of this trademark filing is REGISTERED as of Tuesday, November 17, 2020. This trademark is owned by Douglas Pharmaceuticals Limited. The TASMAN PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders
tasman pharma

General Information

Serial Number87569014
Word MarkTASMAN PHARMA
Filing DateTuesday, August 15, 2017
Status700 - REGISTERED
Status DateTuesday, November 17, 2020
Registration Number6200747
Registration DateTuesday, November 17, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 14, 2018

Trademark Statements

NOT AVAILABLE"PHARMA"
Goods and ServicesPharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 11, 2018
Primary Code005
First Use Anywhere DateWednesday, October 16, 2019
First Use In Commerce DateWednesday, October 16, 2019

Trademark Owner History

Party NameDouglas Pharmaceuticals Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAuckland 0610
NZ
Party NameDouglas Pharmaceuticals Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAuckland 0610
NZ
Party NameDouglas Pharmaceuticals Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAuckland 0610
NZ

Trademark Events

Event DateEvent Description
Friday, August 18, 2017NEW APPLICATION ENTERED
Monday, August 21, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 17, 2017ASSIGNED TO EXAMINER
Monday, November 20, 2017NON-FINAL ACTION WRITTEN
Monday, November 20, 2017NON-FINAL ACTION E-MAILED
Monday, November 20, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 11, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 11, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 11, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 11, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 2, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 25, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 14, 2018PUBLISHED FOR OPPOSITION
Tuesday, August 14, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 9, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 8, 2019SOU TEAS EXTENSION RECEIVED
Monday, April 8, 2019SOU EXTENSION 1 FILED
Monday, April 8, 2019SOU EXTENSION 1 GRANTED
Wednesday, April 10, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 9, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, October 9, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, October 15, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 9, 2019SOU EXTENSION 2 FILED
Tuesday, October 15, 2019SOU EXTENSION 2 GRANTED
Wednesday, October 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 6, 2020SOU TEAS EXTENSION RECEIVED
Monday, April 6, 2020SOU EXTENSION 3 FILED
Monday, April 6, 2020SOU EXTENSION 3 GRANTED
Wednesday, April 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 6, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, October 6, 2020USE AMENDMENT FILED
Friday, October 9, 2020STATEMENT OF USE PROCESSING COMPLETE
Saturday, October 10, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 13, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 17, 2020REGISTERED-PRINCIPAL REGISTER
Monday, November 17, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

pharma tasman diseases disorders dermatological treatment preparations prevention pharmaceutical